Evidence map›Paper›PMID 37837453›Full record

ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2024

Trends in pediatric CNS tumors in Armenia: a multicenter retrospective study.

Julieta Hoveyan, Eduard Asatryan, Henrik Grigoryan, Shushan Hovsepyan, Anna Avagyan, Lusine Hakobyan, Lilit Sargsyan, Samvel Iskanyan, Manushak Avagyan, Saten Hovhannisyan and 14 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Julieta HoveyanDepartment of Pediatric Oncology, Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia. julia.hoveyan95@gmail.com.ORCID 0009-0003-8360-356X
Eduard AsatryanDivision of Neurosurgery, Department of Surgery, Wigmore Hospital for Children, Yerevan, Armenia.
Henrik GrigoryanDepartment of Pediatric Hematology, Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia.
Shushan HovsepyanDepartment of Pediatric Oncology, Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia.
Anna AvagyanDepartment of Pediatric Hematology, Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia.
Lusine HakobyanDepartment of Pediatric Oncology, Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia.
Lilit SargsyanDepartment of Pediatric Oncology, Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia.
Samvel IskanyanDepartment of Pediatric Oncology, Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia.
Manushak AvagyanDepartment of Hematology and Pediatric Oncology, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
Saten HovhannisyanDepartment of Pediatric Oncology, Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia.
Irina MelnichenkoDepartment of Pediatric Oncology, Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia.
Mariam MinasyanDepartment of Pediatric Oncology, Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia.
Ruzanna PapyanDepartment of Pediatric Oncology, Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia.
Narek ManukyanNational Center of Oncology named after V. A. Fanarjyan, Yerevan, Armenia.
Armine LazaryanDepartment of Radiation Oncology, National Center of Oncology named after V. A. Fanarjyan, Yerevan, Armenia.
Samvel DanelyanHematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia.
Armen MuradyanYerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
Jemma ArakelyanCity University of Hong Kong, Hong Kong, China.
Ibrahim QaddoumiDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Frederick BoopGlobal Pediatric Medicine Department, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Armen MkhitharyanHistoGen Pathology Center, Yerevan, Armenia.
Martin HarutyunyanAdult's Solid Tumor Chemotherapy Department, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia.
Gevorg TamamyanDepartment of Pediatric Oncology, Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia.
Samvel BardakhchyanImmune Oncology Research Institute, Yerevan, Armenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCentral nervous system (CNS) tumors are the most common solid malignancies in children worldwide, including in Armenia. The current study aims to analyze epidemiological data, treatment, and outcomes of children and young adults (≤25 years) with CNS tumors in Armenia during the last 26 years.

methodsWe collected data from pediatric and young adult patients treated in selected sites in Armenia from 1

resultsThe multicenter data analysis revealed 149 patients with diagnosed primary CNS tumors over 26 years. Among them, 84 (56.4%) were male. The median age at diagnosis was 7 years (range, 3 months to 25 years), and the median time from the first complaints to diagnosis was 2 months (range, 1 week to 70 months). Medulloblastomas and other embryonal tumors (47), low-grade gliomas (32), and high-grade gliomas (22) were the most commonly diagnosed malignancies. Ependymomas, craniopharyngiomas, germ cell tumors, and other malignancies were observed in 22 patients. For 26 patients, no histopathological or radiological diagnosis was available. Follow-up information was available for 98 (65.8%) patients. The 5-year OS rate for the whole study group was 67.7%.

conclusionConsistent with international data, embryonal tumors, and gliomas were the most commonly diagnosed CNS malignancies in Armenia. Multimodal treatment was often not available in Armenia during the study period, especially for early cases.

Indexed as

Central Nervous System NeoplasmsCerebellar NeoplasmsGliomaPituitary NeoplasmsArmeniaChildFemaleHumansInfantMaleRetrospective StudiesYoung AdultArmeniaCNS tumorsDeveloping countryEpidemiology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.